| IMA Market Cap History Table | ||||||||||
Below is a table of the IMA market cap history going back to 6/30/2025:
Also see: IMA Shares Outstanding History and IMA YTD Return |
As of 4/30/2026 ImageneBio has a market cap of 67.90 million. Investors often follow the IMA market cap history to compare the size of the company over time.
This page shows IMA market capitalization trends over time, with 4 market cap datapoints presented, dating back to 6/30/2025.

| IMA Market Cap History Table | ||||||||||
Below is a table of the IMA market cap history going back to 6/30/2025:
Also see: IMA Shares Outstanding History and IMA YTD Return |
| IMA Market Cap History Chart | ||||||||||||
IMA Historical Market Cap: +6.01% CAGR
Mouse over chart for data details
| ||||||||||||
| IMA Stock Price Chart |
| About ImageneBio Inc |
| Ikena Oncology, Inc. is a targeted oncology company. Co. is focused on developing differentiated therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Co.'s lead targeted oncology program, IK-930, is a transcriptional enhanced associate domain 1 (TEAD1) selective Hippo pathway inhibitor, a known tumor suppressor pathway that also drives resistance to multiple targeted therapies. Co.'s second clinical-stage program targets the RAS signaling pathway with IK-595, a novel MEK-RAF molecular glue. It has IK-175 aryl hydrocarbon receptor (AHR) antagonist program that completed Phase 1 clinical trial. We show 4 historical shares outstanding datapoints in our IMA shares outstanding history coverage, used to compute IMA market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing IMA market cap history over the course of time is important for investors interested in comparing IMA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of IMA versus a peer is one thing; comparing IMA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like IMA can fluctuate over the course of history. With this page we aim to empower investors researching IMA by allowing them to research the IMA market cap history. |
| IMA Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: The Importance of Market Cap | |
|
| IMA Share Performance |
| Market Cap Peers |
| ImageneBio (IMA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
IMAC Market Cap History IMDX Market Cap History IMDZ Market Cap History IMGN Market Cap History IMGO Market Cap History IMMU Market Cap History IMMX Market Cap History IMMY Market Cap History IMNM Market Cap History IMNN Market Cap History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.